title: Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals.
abstract: Human immunodeficiency virus type 1 (HIV-1) infects and destroys cells of the immune system leading to an overt immune deficiency known as HIV acquired immunodeficiency syndrome (HIV/AIDS). The gut associated lymphoid tissue is one of the major lymphoid tissues targeted by HIV-1, and is considered a reservoir for HIV-1 replication and of major importance in CD4+ T-cell depletion. In addition to immunodeficiency, HIV-1 infection also directly causes gastrointestinal (GI) dysfunction, also known as HIV enteropathy. This enteropathy can manifest itself as many pathological changes in the GI tract. The objective of this study was to determine the association of gut HIV-1 infection markers with long-term survival in a cohort of men who have sex with men (MSM) enrolled pre-HAART (Highly Active Antiretroviral Therapy). We examined survival over 15-years in a cohort of 42 HIV-infected cases: In addition to CD4+ T cell counts and HIV-1 plasma viral load, multiple gut compartment (duodenum and colon) biopsies were taken by endoscopy every 6 months during the initial 3-year period. HIV-1 was cultured from tissues and phenotyped and viral loads in the gut tissues were determined. Moreover, the tissues were subjected to an extensive assessment of enteroendocrine cell distribution and pathology. The collected data was used for survival analyses, which showed that patients with higher gut tissue viral load levels had a significantly worse survival prognosis. Moreover, lower numbers of serotonin (duodenum) and somatostatin (duodenum and colon) immunoreactive cell counts in the gut tissues of patients was associated with significant lower survival prognosis. Our study, suggested that HIV-1 pathogenesis and survival prognosis is associated with altered enteroendocrine cell numbers, which could point to a potential role for enteroendocrine function in HIV infection and pathogenesis.
authors.affiliation: Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada ; Department of Microbiology, Immunology & Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
authors.forename: Guido
authors.initials: G
authors.lastname: van Marle
authors.forename: Keith A
authors.initials: KA
authors.lastname: Sharkey
authors.forename: M John
authors.initials: MJ
authors.lastname: Gill
authors.forename: Deirdre L
authors.initials: DL
authors.lastname: Church
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology / Q000821:virology*; D002452:Cell Count; D003106:Colon / Q000276:immunology / Q000473:pathology / Q000821:virology*; D004386:Duodenum / Q000276:immunology / Q000473:pathology / Q000821:virology*; D019858:Enteroendocrine Cells / Q000276:immunology / Q000473:pathology / Q000821:virology*; D015658:HIV Infections / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000821:virology*; D015497:HIV-1; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D008875:Middle Aged; D012701:Serotonin / Q000378:metabolism; D013004:Somatostatin / Q000378:metabolism; D016019:Survival Analysis; D019562:Viral Load
chemical_list: D015415:Biomarkers; D012701:Serotonin; D013004:Somatostatin